Resources Contact Us Home
Buschard; Karsten
Charlottenlund, DK
No. of patents:

Patent Number Title Of Patent Date Issued
6492337 Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use i December 10, 2002
The use of glycolipids, in particular galactosylceramide, glucosylceramide and lactosylceramide, and specific catchers therefor (antibodies or lectins), in particular monoclonal antibodies, for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in
6352831 Glycolipid complexes and their uses March 5, 2002
A complex between a water-soluble polymer containing hydrophobic regions and a glycolipid, immunoassays utilizing the complex as an immune reagent and diagnostic methods to be used in the context of neuropathy and insulin-dependent diabetes. The diagnostic methods employ anti-glycolipid
5827828 Sulfated glycolipids and antibodies thereto for prophylaxis or therapy of diabetes October 27, 1998
Methods for the treatment of prediabetes or diabetes in an individual comprise administering to the individual a therapeutically active agent comprising a glycolipid having a galactose-3-O-sulfate moiety capable of binding to islet cell antibodies. Methods of detecting or quantifying

  Recently Added Patents
Method and apparatus for laser strip splicing
Apparatus and method for adapted deblocking filtering strength
Modulation of HSP47 expression
Lubricating oil compositions
Cellulose derivative and hydrogel thereof
Target trading system and method
  Randomly Featured Patents
Spirodiphosphoamidate compounds
Outlet cover
Poker game with spoken ranks
Biometric authentication device, biometric information authentication method, and program
Method and apparatus for measuring transmitted optical distortion in glass sheets
Method of manufacturing semiconductor device
Alignment and exposure apparatus and method for manufacture of integrated circuits
Software for mapping potential distribution of a heart chamber
Recording tape cartridge
System and method for controlled delivery of a therapeutic agent to a target location within an internal body tissue